Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human-cl rhFVIII pharmacokinetic and prophylaxis study in previously treated adults with severe haemophilia A
ISRCTN87293301Phase 2Completed
- Sponsor
- Octapharma
- Start
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 2, open-label trial of simoctocog alfa in hemophilia A (2 arms), sponsored by Octapharma. Primary endpoint: Area under the curve for factor VIII activity. Started Mar 2009; status: completed.
02
Drugs
simoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on ISRCTN87293301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN87293301.